# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY

I Background Information:

A 510(k) Number K193318 B Applicant

Acon Laboratories Inc.

C Proprietary and Established Names

Distinct $\textsuperscript { \textregistered }$ Early Detection Pregnancy Test

D Regulatory Information

<table><tr><td rowspan=1 colspan=1>ProductCode(s)</td><td rowspan=1 colspan=1>Classification</td><td rowspan=1 colspan=1>RegulationSection</td><td rowspan=1 colspan=1>Panel</td></tr><tr><td rowspan=1 colspan=1>LCX</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>21 CFR 862.1155 - HumanChorionic Gonadotropin(HCG) Test System</td><td rowspan=1 colspan=1>CH - ClinicalChemistry</td></tr></table>

# II Submission/Device Overview:

A Purpose for Submission: New Device   
B Measurand: Human chorionic gonadotropin (hCG)   
C Type of Test: Qualitative chromatographic immunoassay

# III Intended Use/Indications for Use:

A Intended Use(s): See Indications for Use below.

# B Indication(s) for Use:

The Distinct $\textsuperscript { \textregistered }$ Early Detection Pregnancy Test is an aid for the early detection of pregnancy intended for home use. The device is a chromatographic immunoassay that performs qualitative detection of human chorionic gonadotropin (hCG) in urine. This test can help determine pregnancy as early as 6 days before the day of the missed period (5 days before the day of the expected period)

# D Special Instrument Requirements:

Not applicable.

# IV Device/System Characteristics:

# A Device Description:

The Distinct $\textsuperscript { \textregistered }$ Early Detection Pregnancy Test is a rapid chromatographic immunoassay for in vitro qualitative detection of human chorionic gonadotropin in urine to aid in the early detection of pregnancy. It is for self-testing. The test strip and absorbent tip are assembled in a plastic housing.

# B Principle of Operation:

The test strip contains monoclonal anti-hCG antibodies and goat anti-mouse polyclonal antibodies. The test result is shown in the result window and read visually after 3 minutes of urine application.

A blue sign of plus $( + )$ at the test window indicates that hCG has been detected (pregnant). Absence of the plus $( + )$ and only a blue line (-) in the Test Window suggests no hCG has been detected. To serve as a procedural control, a blue line will always appear in the Control Window indicating that proper volume of specimen has been added and membrane wicking has occurred.

# V Substantial Equivalence Information:

A Predicate Device Name(s): First Response Early Result Pregnancy Test   
B Predicate 510(k) Number(s): K123436

# C Comparison with Predicate(s):

<table><tr><td rowspan=1 colspan=1>Device &amp; PredicateDevice(s):</td><td rowspan=1 colspan=1>K193318</td><td rowspan=1 colspan=1>K123436</td></tr><tr><td rowspan=1 colspan=1>Device Trade Name</td><td rowspan=1 colspan=1>Distinct® EarlyDetection PregnancyTest</td><td rowspan=1 colspan=1>First Response EarlyResult Pregnancy Test</td></tr><tr><td rowspan=1 colspan=1>General DeviceCharacteristic Similarities</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Intended Use/IndicationsFor Use</td><td rowspan=1 colspan=1>Qualitative detection ofhuman chorionicgonadotropin in urine toaid in the earlydetection of pregnancy</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Specimen</td><td rowspan=1 colspan=1>Urine</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Indications/Intended Users</td><td rowspan=1 colspan=1>Over the Counter(OTC)</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Test Principle</td><td rowspan=1 colspan=1>Lateral FlowImmunoassay</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Format</td><td rowspan=1 colspan=1>Dip and Midstream</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Detection Time</td><td rowspan=1 colspan=1>Early detection ofpregnancy; 5 daysbefore the expectedperiod (6 days beforethe day of the missedperiod)</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>General DeviceCharacteristic Differences</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Traceability</td><td rowspan=1 colspan=1>WHO 5th InternationalStandard for hCG</td><td rowspan=1 colspan=1>WHO 4th InternationalStandard for hCG</td></tr><tr><td rowspan=1 colspan=1>Read Time</td><td rowspan=1 colspan=1>3 to 10 minutes</td><td rowspan=1 colspan=1>3 minutes</td></tr></table>

# VI Standards/Guidance Documents Referenced:

CLSI EP07 Interference Testing in Clinical Chemistry.

VII Performance Characteristics (if/when applicable):

# A Analytical Performance:

# 1. Precision/Reproducibility:

The sponsor performed a study to evaluate the imprecision of the device with different trained operators using both formats. Thirty negative urine specimens were collected and spiked with WHO $5 ^ { \mathrm { t h } }$ International hCG standard to the following concentrations: 3, 6, 8, 10,

12, and $1 5 \mathrm { m I U / m L }$ . Results were read in duplicate by three operators over five days and the results were read at 3 and 10 minutes using three lots of the device. Results are summarized below:

Dip Method:   

<table><tr><td rowspan=1 colspan=1>hCG levels(mIU/ml)</td><td rowspan=1 colspan=1>Result</td><td rowspan=1 colspan=1>% Positive</td></tr><tr><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>Negative 90Positive 0</td><td rowspan=1 colspan=1>0%</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>Negative 90Positive 0</td><td rowspan=1 colspan=1>0%</td></tr><tr><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>Negative 56Positive 34</td><td rowspan=1 colspan=1>37.8%</td></tr><tr><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>Negative 28Positive 62</td><td rowspan=1 colspan=1>68.9%</td></tr><tr><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>Negative 0Positive 90</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>Negative 0Positive 90</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>Negative 0Positive 90</td><td rowspan=1 colspan=1>100%</td></tr></table>

Simulated Urine Stream Method:   

<table><tr><td rowspan=1 colspan=1>hCG levels(mIU/ml)</td><td rowspan=1 colspan=1>Result</td><td rowspan=1 colspan=1>% Positive</td></tr><tr><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>Negative 90Positive 0</td><td rowspan=1 colspan=1>0%</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>Negative 90Positive 0</td><td rowspan=1 colspan=1>0%</td></tr><tr><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>Negative 61Positive 29</td><td rowspan=1 colspan=1>32.2%</td></tr><tr><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>Negative 17Positive 73</td><td rowspan=1 colspan=1>81.1%</td></tr><tr><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>Negative 0Positive 90</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>Negative 0Positive 90</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>Negative 0Positive 90</td><td rowspan=1 colspan=1>100%</td></tr></table>

The sponsor also performed a study to evaluate the imprecision of the device using both formats when read by laypersons.

Thirty negative urine specimens were collected and spiked with WHO $5 ^ { \mathrm { t h } }$ International hCG standard to the following concentrations: 3, 5, 6, 7.5, 8, 8.5, 10, 12, 15 and $2 5 \mathrm { m I U / m l }$ . The samples were blinded and randomized prior to being read. A total of 300 lay users performed the test using three lots of the devices; however, the total number of readings was not identical for each concentration, as specified below. Results are summarized below:

Dip Method:   

<table><tr><td rowspan=1 colspan=1>hCG levels(mIU/ml)</td><td rowspan=1 colspan=1>Number ofresults at thisconcentration</td><td rowspan=1 colspan=1>Results</td><td rowspan=1 colspan=1>% Positive</td></tr><tr><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>Negative 84Positive 0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>81</td><td rowspan=1 colspan=1>Negative 81Positive 0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>81</td><td rowspan=1 colspan=1>Negative 70Positive 11</td><td rowspan=1 colspan=1>14</td></tr><tr><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>81</td><td rowspan=1 colspan=1>Negative 50Positive 31</td><td rowspan=1 colspan=1>38</td></tr><tr><td rowspan=1 colspan=1>7.5</td><td rowspan=1 colspan=1>81</td><td rowspan=1 colspan=1>Negative 38Positive 43</td><td rowspan=1 colspan=1>53</td></tr><tr><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>81</td><td rowspan=1 colspan=1>Negative 25Positive 56</td><td rowspan=1 colspan=1>69</td></tr><tr><td rowspan=1 colspan=1>8.5</td><td rowspan=1 colspan=1>81</td><td rowspan=1 colspan=1>Negative 20Positive 61</td><td rowspan=1 colspan=1>75</td></tr><tr><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>81</td><td rowspan=1 colspan=1>Negative 0Positive 81</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>81</td><td rowspan=1 colspan=1>Negative 0Positive 81</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>Negative 0Positive 84</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>25</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>Negative 0Positive 84</td><td rowspan=1 colspan=1>100</td></tr></table>

# Simulated Urine Stream Method:

<table><tr><td rowspan=1 colspan=1>hCG levels(mIU/ml)</td><td rowspan=1 colspan=1>Number ofresults at thisconcentration</td><td rowspan=1 colspan=1>Result</td><td rowspan=1 colspan=1>% Positive</td></tr><tr><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>Negative 84Positive 0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>81</td><td rowspan=1 colspan=1>Negative 81Positive 0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>81</td><td rowspan=1 colspan=1>Negative 68Positive 13</td><td rowspan=1 colspan=1>16</td></tr><tr><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>81</td><td rowspan=1 colspan=1>Negative 52Positive 29</td><td rowspan=1 colspan=1>36</td></tr><tr><td rowspan=1 colspan=1>7.5</td><td rowspan=1 colspan=1>81</td><td rowspan=1 colspan=1>Negative 41Positive 40</td><td rowspan=1 colspan=1>49</td></tr><tr><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>81</td><td rowspan=1 colspan=1>Negative 26Positive 55</td><td rowspan=1 colspan=1>68</td></tr><tr><td rowspan=1 colspan=1>8.5</td><td rowspan=1 colspan=1>81</td><td rowspan=1 colspan=1>Negative 22Positive 59</td><td rowspan=1 colspan=1>73</td></tr><tr><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>81</td><td rowspan=1 colspan=1>Negative 0Positive 81</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>81</td><td rowspan=1 colspan=1>Negative 0Positive 81</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>Negative 0Positive 84</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>25</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>Negative 0Positive 84</td><td rowspan=1 colspan=1>100</td></tr></table>

2. Linearity:

Not Applicable. This is a qualitative test.

3. Analytical Specificity/Interference:

# Cross-Reactivity

The sponsor performed a study to evaluate potential cross-reactivity from LH, FSH and TSH with the candidate device by measuring hCG in samples with various concentrations of hCG, LH, FSH and TSH as specified in the table below.

<table><tr><td rowspan=1 colspan=1>Solution</td><td rowspan=1 colspan=1>Concentrations</td></tr><tr><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0 mIU/mL and 1000 mIU/mL FSH</td></tr><tr><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0 mIU/mL and 1000 mIU/mL LH</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>0 mIU/mL and 1000 μIU/mL TSH</td></tr><tr><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>3 mIU/mL hCG and 1000 mIU/mL FSH</td></tr><tr><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>3 mIU/mL hCG and 1000 mIU/mL LH</td></tr><tr><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>3 mIU/mL hCG and 1000 μIU/mL TSH</td></tr><tr><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>10 mIU/mL hCG and 1000 mIU/mL FSH</td></tr><tr><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>10 mIU/mL hCG and 1000 mIU/mL LH</td></tr><tr><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>10 mIU/mL hCG and 1000 μIU/mL TSH</td></tr></table>

The prepared samples were tested with the candidate device in triplicate using three lots and the results were read at 3 and 10 minutes. All results at 0 and $3 \ \mathrm { m I U / m L }$ were negative and all results at $1 0 \ \mathrm { m I U / m L }$ were positive.

# Interfering Substances

The sponsor performed a study to evaluate potential interference from common exogenous and endogenous compounds. Negative urine was spiked with potentially interfering substances and hCG standard solution to the concentrations listed in the table below.

Spiked samples were tested in triplicate using one lot of the candidate device. There were no deviations from the expected positive or negative results. Results are summarized below.

Endogenous Substances

<table><tr><td rowspan=1 colspan=1>Analyte</td><td rowspan=1 colspan=1>ConcentrationTested</td><td rowspan=1 colspan=1>Results at 0mIU/mL hCG</td><td rowspan=1 colspan=1>Results at 3mIU/mL hCG</td><td rowspan=1 colspan=1>Results at 10mIU/mL hCG</td></tr><tr><td rowspan=1 colspan=1>Bilirubin</td><td rowspan=1 colspan=1>50 mg/dL</td><td rowspan=1 colspan=1>3 neg / 0 pos</td><td rowspan=1 colspan=1>3 neg / 0 pos</td><td rowspan=1 colspan=1>0 neg / 3 pos</td></tr><tr><td rowspan=1 colspan=1>Hemoglobin</td><td rowspan=1 colspan=1>1000 mg/dL</td><td rowspan=1 colspan=1>3 neg / 0 pos</td><td rowspan=1 colspan=1>3 neg// 0 pos</td><td rowspan=1 colspan=1>0 neg / 3 pos</td></tr><tr><td rowspan=1 colspan=1>Albumin</td><td rowspan=1 colspan=1>2000 mg/dL</td><td rowspan=1 colspan=1>3 neg / 0 pos</td><td rowspan=1 colspan=1>3 neg/ / 0 pos</td><td rowspan=1 colspan=1>0 neg / 3 pos</td></tr><tr><td rowspan=1 colspan=1>Glucose</td><td rowspan=1 colspan=1>2000 mg/dL</td><td rowspan=1 colspan=1>3 neg / 0 pos</td><td rowspan=1 colspan=1>3 neg/ 0 pos</td><td rowspan=1 colspan=1>0 neg/ 3 pos</td></tr><tr><td rowspan=1 colspan=1>Urea</td><td rowspan=1 colspan=1>2000 mg/dL</td><td rowspan=1 colspan=1>3 neg / 0 pos</td><td rowspan=1 colspan=1>3 neg// 0 pos</td><td rowspan=1 colspan=1>0 neg/ / 3 pos</td></tr><tr><td rowspan=1 colspan=1>Uric acid</td><td rowspan=1 colspan=1>150 mg/dL</td><td rowspan=1 colspan=1>3 neg / 0 pos</td><td rowspan=1 colspan=1>3 neg// 0 pos</td><td rowspan=1 colspan=1>0 neg / 3 pos</td></tr><tr><td rowspan=1 colspan=1>Oxalic acid</td><td rowspan=1 colspan=1>50 mg/dL</td><td rowspan=1 colspan=1>3 neg / 0 pos</td><td rowspan=1 colspan=1>3 neg// 0 pos</td><td rowspan=1 colspan=1>0 neg/ / 3 pos</td></tr><tr><td rowspan=1 colspan=1>Creatinine</td><td rowspan=1 colspan=1>250 mg/ dL</td><td rowspan=1 colspan=1>3 neg / 0 pos</td><td rowspan=1 colspan=1>3 neg / 0 pos</td><td rowspan=1 colspan=1>0 neg / 3 pos</td></tr><tr><td rowspan=1 colspan=1>Sodium nitrite</td><td rowspan=1 colspan=1>10 mg/dL</td><td rowspan=1 colspan=1>3 neg / 0 pos</td><td rowspan=1 colspan=1>3 neg / 0 pos</td><td rowspan=1 colspan=1>0 neg / 3 pos</td></tr></table>

Exogenous Substances  

<table><tr><td rowspan=1 colspan=1>Analyte</td><td rowspan=1 colspan=1>ConcentrationTested</td><td rowspan=1 colspan=1>Results at 0mIU/mL hCG</td><td rowspan=1 colspan=1>Results at 3mIU/mL hCG</td><td rowspan=1 colspan=1>Results at 10mIU/mL hCG</td></tr><tr><td rowspan=1 colspan=1>Acetaminophen</td><td rowspan=1 colspan=1>20 mg/dL</td><td rowspan=1 colspan=1>3 neg / 0 pos</td><td rowspan=1 colspan=1>3 neg / 0 pos</td><td rowspan=1 colspan=1>0 neg / 3 pos</td></tr><tr><td rowspan=1 colspan=1>Ascorbic Acid</td><td rowspan=1 colspan=1>20 mg/dL</td><td rowspan=1 colspan=1>3 neg / 0 pos</td><td rowspan=1 colspan=1>3 neg //0 pos</td><td rowspan=1 colspan=1>0 neg / 3 pos</td></tr><tr><td rowspan=1 colspan=1>Caffeine</td><td rowspan=1 colspan=1>20 mg/dL</td><td rowspan=1 colspan=1>3 neg/g / 0 pos</td><td rowspan=1 colspan=1>3 neg / 0 pos</td><td rowspan=1 colspan=1>0 neg / 3 pos</td></tr><tr><td rowspan=1 colspan=1>Gentisic Acid</td><td rowspan=1 colspan=1>20 mg/dL</td><td rowspan=1 colspan=1>3 neg// 0 pos</td><td rowspan=1 colspan=1>3 neg/0 pos</td><td rowspan=1 colspan=1>0 neg //3 pos</td></tr><tr><td rowspan=1 colspan=1>Salicylic Acid</td><td rowspan=1 colspan=1>20 mg/dL</td><td rowspan=1 colspan=1>3 neg// 0 pos</td><td rowspan=1 colspan=1>3 neg/0 pos</td><td rowspan=1 colspan=1>0 neg//3 pos</td></tr><tr><td rowspan=1 colspan=1>Acetylsalicylic</td><td rowspan=1 colspan=1>20 mg/dL</td><td rowspan=1 colspan=1>3 neg/0 pos</td><td rowspan=1 colspan=1>3 neg//0 pos</td><td rowspan=1 colspan=1>0 neg//3 pos</td></tr><tr><td rowspan=1 colspan=1>Ethanol</td><td rowspan=1 colspan=1>1.0 %</td><td rowspan=1 colspan=1>3 neg// 0 pos</td><td rowspan=1 colspan=1>3 negg / 0 pos</td><td rowspan=1 colspan=1>0 neg / 3 pos</td></tr><tr><td rowspan=1 colspan=1>Tetracycline</td><td rowspan=1 colspan=1>20 mg/dL</td><td rowspan=1 colspan=1>3 neg/ / 0 pos</td><td rowspan=1 colspan=1>3 neg / 0 pos</td><td rowspan=1 colspan=1>0 neg / 3 pos</td></tr><tr><td rowspan=1 colspan=1>Theophylline</td><td rowspan=1 colspan=1>20 mg/dL</td><td rowspan=1 colspan=1>3 neg/ 0 pos</td><td rowspan=1 colspan=1>3 neg / 0 pos</td><td rowspan=1 colspan=1>0 neg / 3 pos</td></tr><tr><td rowspan=1 colspan=1>Ibuprofen</td><td rowspan=1 colspan=1>50 mg/dL</td><td rowspan=1 colspan=1>3 neg / 0 pos</td><td rowspan=1 colspan=1>3 neg / 0 pos</td><td rowspan=1 colspan=1>0 neg / 3 pos</td></tr><tr><td rowspan=1 colspan=1>EDTA</td><td rowspan=1 colspan=1>80 mg/dL</td><td rowspan=1 colspan=1>3 neg / 0 pos</td><td rowspan=1 colspan=1>3 neg / 0 pos</td><td rowspan=1 colspan=1>0 neg / 3 pos</td></tr></table>

# Effects of Urine pH

The sponsor performed a study to evaluate the effect of urine $\mathsf { p H }$ on the results. A negative urine pool was split and separately adjusted in $\mathsf { p H }$ increments of 1.0 from $\mathsf { p H 4 . 0 }$ to 9.0. Aliquots of each $\mathsf { p H }$ adjusted urine sample were then spiked with hCG to concentrations of 3 and $1 0 \ \mathrm { m I U / m L }$ and read at 3 and 10 minutes. There were no deviations from the expected positive or negative results.

# Specific Gravity

The sponsor performed a study to evaluate the effect of urine specific gravity on the results. A negative urine pool was split and adjusted with sodium chloride or purified water to produce samples with a specific gravity ranging from 1.003 – 1.035. Aliquots of each specific gravity adjusted urine sample were then spiked with hCG to concentrations of 3 and $1 0 \mathrm { m I U / m L }$ and read at 3 and 10 minutes. There were no deviations from the expected positive or negative results.

# High Dose Hook Effect Study

The sponsor performed a study to evaluate whether very high concentrations of hCG could produce a hook effect with the candidate device. Samples were prepared by spiking a negative urine pool with hCG to concentrations of 500, 1,000, 10,000, 100,000, 500,000 and $1 , 0 0 0 , 0 0 0 \mathrm { m I U / m L }$ . Sample were tested in triplicate using three lots of the device. All concentrations of hCG with all three lots produced the expected positive results and no hook effect was observed.

# 4. Assay Reportable Range:

Not applicable. This is a qualitative test.

Traceability:

The test is calibrated against the WHO 5th International Standard (IS) for Chorionic Gonadotrophin (hCG).

Stability:

The shelf life of the Distinct $\textsuperscript { \textregistered }$ Early Detection Pregnancy Test were verified by accelerated, open pouch and on-going real-time stability studies. From the results of the study, it was concluded that Distinct $\textsuperscript { \textregistered }$ Early Detection Pregnancy Test is stable at $5 5 \mathrm { { ^ \circ C } }$ for 10 weeks and $4 5 \mathrm { { ^ \circ C } }$ for 22 weeks which support the shelf life up to 24 months at $2 - 3 0 ^ { \circ } \mathrm { ~ C ~ } ( 3 6 - 8 6 ^ { \circ } \mathrm { F } )$ .

6. Detection Limit: See section VII.A.1 above.

7. Assay Cut-Off:

The claimed cutoff of the assay is $1 0 \ \mathrm { m I U / m L }$ . See section VII.A.1 above for performance around the cutoff.

# B Comparison Studies:

# 1. Method Comparison with Predicate Device:

The sponsor performed a combined lay user and method comparison study to evaluate the accuracy of the candidate device. A total of 205 volunteer participants (lay users) were recruited at three clinical sites with 68 or 69 participants at each clinical site. Laypersons tested their own urine samples using the Distinct $\textsuperscript { \textregistered }$ Early Pregnancy Test followed the directions in the package insert. Approximately half of the subjects used the dip method and half used the midstream method. Trained laboratory professionals then tested the same urine samples using the candidate device and the predicate device. The samples were blind labeled before being given to the laboratory professionals for testing. Three lots of the candidate device were used in the study and the results are summarized below:

Candidate device (layperson) vs. predicate device (professional)

<table><tr><td colspan="2" rowspan="2">Urine stream Method</td><td colspan="3" rowspan="1">Predicate (Professional)</td></tr><tr><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Total</td></tr><tr><td colspan="1" rowspan="3">Candidate(Layperson)</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">51</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">51</td></tr><tr><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">51</td><td colspan="1" rowspan="1">51</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">51</td><td colspan="1" rowspan="1">51</td><td colspan="1" rowspan="1">102</td></tr><tr><td colspan="2" rowspan="2">Urine Dipping Method</td><td colspan="3" rowspan="1">Predicate (Professional)</td></tr><tr><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Total</td></tr><tr><td colspan="1" rowspan="3">Candidate(Layperson)</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">52</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">52</td></tr><tr><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">51</td><td colspan="1" rowspan="1">51</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">52</td><td colspan="1" rowspan="1">51</td><td colspan="1" rowspan="1">103</td></tr></table>

Candidate device (professional) vs. predicate device (professional)

<table><tr><td rowspan=2 colspan=2>Urine stream Method</td><td rowspan=1 colspan=3>Predicate (Professional)</td></tr><tr><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Total</td></tr><tr><td rowspan=3 colspan=1>Candidate(Professional)</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>51</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>51</td></tr><tr><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>51</td><td rowspan=1 colspan=1>51</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>51</td><td rowspan=1 colspan=1>51</td><td rowspan=1 colspan=1>102</td></tr></table>

<table><tr><td rowspan=2 colspan=2>Urine Dipping Method</td><td rowspan=1 colspan=3>Predicate (Professional)</td></tr><tr><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Total</td></tr><tr><td rowspan=3 colspan=1>Candidate(Professional)</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>52</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>52</td></tr><tr><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>51</td><td rowspan=1 colspan=1>51</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>52</td><td rowspan=1 colspan=1>51</td><td rowspan=1 colspan=1>103</td></tr></table>

After testing, subjects were asked to complete a questionnaire to collect feedback on the test including ease of use, clarity and readability of the package insert. All of the participants reported that the test instructions were easy to follow and that it was easy to read the test results.

2. Matrix Comparison:

Not applicable. The device is intended for use with urine samples only.

# C Clinical Studies:

1. Clinical Sensitivity: Not Applicable.

2. Clinical Specificity:

# Specificity Study to Determine False-Positive Results Rate

A study was performed to determine the incidence of positive test results using the candidate device among non-pregnant women in three age groups: 18-40, 41-45, and 55 and older. A

total of 300 subjects provided samples with 100 for each age group. Three lots of the candidate device were used for this study. No positive results were observed for any of the age groups.

3. Other Clinical Supportive Data (When 1. and 2. Are Not Applicable):

# Detection of hCG in Early Pregnancy Clinical Samples

Urine from 65 non-pregnant women expecting to become pregnant were collected daily starting 8 days prior to their expected period through the date of their expected menstrual period (EMP), as well as the 6th or 7th day after their EMP. Each patient collected her own urine and sent the sample to a clinical site where they were tested by a laboratory professional. Three lots of the candidate device were used and the pregnancy status was confirmed by ultrasound or a quantitative blood hCG result.

<table><tr><td rowspan=1 colspan=1>Time Point</td><td rowspan=1 colspan=1>Number ofPositive</td><td rowspan=1 colspan=1>Number ofNegative</td><td rowspan=1 colspan=1>% Positive</td></tr><tr><td rowspan=1 colspan=1>EMP +6 or 7 days</td><td rowspan=1 colspan=1>65</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>EMP</td><td rowspan=1 colspan=1>65</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>EMP-1 day</td><td rowspan=1 colspan=1>65</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>EMP-2 days</td><td rowspan=1 colspan=1>65</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>EMP-3 days</td><td rowspan=1 colspan=1>63</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>96.9%</td></tr><tr><td rowspan=1 colspan=1>EMP-4 days</td><td rowspan=1 colspan=1>61</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>93.8%</td></tr><tr><td rowspan=1 colspan=1>EMP-5 days</td><td rowspan=1 colspan=1>49</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>75.4%</td></tr><tr><td rowspan=1 colspan=1>EMP-6 days</td><td rowspan=1 colspan=1>32</td><td rowspan=1 colspan=1>33</td><td rowspan=1 colspan=1>49.2%</td></tr><tr><td rowspan=1 colspan=1>EMP-7 days</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>51</td><td rowspan=1 colspan=1>20.3%</td></tr><tr><td rowspan=1 colspan=1>EMP-8 days</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>54</td><td rowspan=1 colspan=1>10.0%</td></tr></table>

D Clinical Cut-Off: Not applicable.   
E Expected Values/Reference Range: Not applicable.

# VIII Proposed Labeling:

The labeling supports the finding of substantial equivalence for this device.

# IX Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.